Related Experiment Video
Updated: Jun 21, 2026
06:54
A Modified Inflammatory Pain Model to Study the Analgesic Effect in Mice
Published on: November 15, 2024
Structure-analgesic activity relationship studies on the C(18)- and C(19)-diterpenoid alkaloids
Jian-Li Wang1, Xiang-Li Shen, Qiao-Hong Chen
1Department of Chemistry of Medicinal Natural Products, West China of Pharmacy, Sichuan University, P.R. China.
Chemical & Pharmaceutical Bulletin
|August 5, 2009
Summary
New diterpenoid alkaloids from Aconitum species show potent analgesic effects. Structure-activity relationships highlight key features for enhanced pain relief, offering potential for novel pain management therapies.
Area of Science:
- Natural Products Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Diterpenoid alkaloids from Aconitum species are known for diverse biological activities.
- Exploring novel analgesic compounds is crucial for effective pain management.
Purpose of the Study:
- To evaluate the analgesic potential of C(18)- and C(19)-diterpenoid alkaloids.
- To identify key structural features contributing to analgesic activity.
Main Methods:
- Isolation of natural alkaloids from Aconitum hemsleyanum var. circinatum and A. transsecutum.
- Synthesis of 25 semi-synthetic C(18)- and C(19)-diterpenoid alkaloids.
- Acetic acid-induced abdominal constriction assay in mice to assess analgesic activity.
Main Results:
- Four crassicauline A analogs and three yunaconitine analogs demonstrated significant analgesic activity (77.8-94.1% inhibition).
- 8-O-deacetyl-8-O-ethylcrassicauline A (ED(50)=0.0972 mg/kg) and 8-O-ethylyunaconitine (ED(50)=0.0591 mg/kg) were identified as the most potent analgesics.
- Key structural features for C(19)-diterpenoid analgesic activity include a tertiary amine in ring A, C-8 substitution, C-14 aromatic ester, and ring D saturation.
Conclusions:
- Several semi-synthetic diterpenoid alkaloids exhibit potent analgesic properties.
- Structural modifications can significantly enhance the analgesic efficacy of these compounds.
- Findings provide insights into the structure-activity relationship of diterpenoid alkaloids for pain relief.
Related Concept Videos
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:30Local Anesthetics: Chemistry and Structure-Activity Relationship
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...